Тестовый ингредиент: различия между версиями
Khodakov (обсуждение | вклад) Нет описания правки |
Khodakov (обсуждение | вклад) Нет описания правки |
||
| Строка 18: | Строка 18: | ||
* Increases ceramide synthesis that results in a stronger, healthier skin barrier and better skin hydration | * Increases ceramide synthesis that results in a stronger, healthier skin barrier and better skin hydration | ||
* Can help to improve several skin conditions including acne, rosacea, and atopic dermatitis | * Can help to improve several skin conditions including acne, rosacea, and atopic dermatitis | ||
== Справочная информация об ингредиенте == | |||
# Walocko, Frances M., et al. "The role of nicotinamide in acne treatment." Dermatologic Therapy (2017). | |||
# Journal of Cosmetic Dermatology, Volume 13 (4) – Dec 1, 2014, A review of nicotinamide: treatment of skin diseases and potential side effects | |||
# Skin Pharmacol Physiol 2014;27:311-315, Niacinamide - Mechanisms of Action and Its Topical Use in Dermatology | |||
# Journal of cosmetic dermatology, 2004 Apr;3(2):88-93., Nicotinic acid/niacinamide and the skin. | |||
# Shalita, Alan R., et al. "Topical nicotinamide compared with clindamycin gel in the treatment of inelammatory acne vulgaris." International journal of dermatology 34.6 (1995): 434-437. | |||
# Navarrete-Solís, Josefina, et al. "A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma." Dermatology research and practice 2011 (2011). | |||
# Tanno, O., et al. "Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier." British Journal of Dermatology 143.3 (2000): 524-531. | |||
== Примечания == | == Примечания == | ||
<references /> | <references /> | ||